Cargando…
Combined olaparib and oxaliplatin inhibits tumor proliferation and induces G(2)/M arrest and γ-H2AX foci formation in colorectal cancer
BACKGROUND: Poly (ADP-ribose) polymerase 1 (PARP1) has an important role in homologous recombination repair. The purpose of this study was to investigate the effect of PARP1 inhibitor on oxaliplatin treatment for colorectal cancer (CRC). METHODS: A cell counting kit-8 assay was used to determine the...
Autores principales: | Xu, Kaiwu, Chen, Zhihui, Cui, Yi, Qin, Changjiang, He, Yulong, Song, Xinming |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4622093/ https://www.ncbi.nlm.nih.gov/pubmed/26543375 http://dx.doi.org/10.2147/OTT.S89154 |
Ejemplares similares
-
miR-7 inhibits colorectal cancer cell proliferation and induces apoptosis by targeting XRCC2
por: Xu, Kaiwu, et al.
Publicado: (2014) -
PARP inhibitor olaparib enhances the efficacy of radiotherapy on XRCC2-deficient colorectal cancer cells
por: Qin, Changjiang, et al.
Publicado: (2022) -
XRCC2 rs3218536 polymorphism decreases the sensitivity of colorectal cancer cells to poly(ADP-ribose) polymerase 1 inhibitor
por: XU, KAIWU, et al.
Publicado: (2014) -
XRCC2 Promotes Colorectal Cancer Cell Growth, Regulates Cell Cycle Progression, and Apoptosis
por: Xu, Kaiwu, et al.
Publicado: (2014) -
Spontaneous γH2AX foci in human dermal fibroblasts in relation to proliferation activity and aging
por: Zorin, Vadim, et al.
Publicado: (2019)